• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管输注20%氧合全氟三丙胺乳剂预防经皮腔内冠状动脉成形术期间的局部缺血。

Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.

作者信息

Cleman M, Jaffee C C, Wohlgelernter D

出版信息

Circulation. 1986 Sep;74(3):555-62. doi: 10.1161/01.cir.74.3.555.

DOI:10.1161/01.cir.74.3.555
PMID:2943533
Abstract

Catheter balloon inflation performed during percutaneous transluminal coronary angioplasty (PTCA) results in temporary interruption of coronary blood flow and subsequent myocardial ischemia. This produces transient but profound regional left ventricular dysfunction. In an effort to mitigate this inflation-related dysfunction, oxygenated Fluosol DA 20%, a perfluorochemical oxygen transport fluid, was infused distal to the balloon through the central lumen of the dilating catheter during balloon inflation. Regional wall motion during PTCA was assessed by simultaneous continuous two-dimensional echocardiography and was quantified by computer analysis. During control inflations accompanied by no intracoronary infusion or by transcatheter infusion of Ringer's lactate solution or nonoxygenated Fluosol DA 20%, there was profound regional left ventricular dysfunction with a greater than 90% decrease in regional contraction. In contrast, regional contraction during transcatheter infusion of oxygenated Fluosol DA 20% remained at normal levels throughout balloon inflation. Distal infusion of Fluosol DA 20% during balloon inflation is a useful adjunct to PTCA, allowing longer inflation times and perhaps permitting PTCA to be performed safely in patients with significant myocardium at ischemic risk or with limited left ventricular reserve for whom the procedure is currently believed to be too hazardous.

摘要

经皮腔内冠状动脉成形术(PTCA)期间进行的导管球囊充盈会导致冠状动脉血流暂时中断并随后引发心肌缺血。这会产生短暂但严重的局部左心室功能障碍。为了减轻这种与充盈相关的功能障碍,在球囊充盈期间,通过扩张导管的中心腔将20%的含氧全氟萘烷(Fluosol DA),一种全氟化学氧运输液,注入球囊远端。PTCA期间的局部壁运动通过同步连续二维超声心动图进行评估,并通过计算机分析进行量化。在未进行冠状动脉内输注或通过导管输注乳酸林格液或不含氧的20%全氟萘烷的对照充盈期间,存在严重的局部左心室功能障碍,局部收缩下降超过90%。相比之下,在整个球囊充盈过程中,通过导管输注20%含氧全氟萘烷期间的局部收缩保持在正常水平。在球囊充盈期间远端输注20%全氟萘烷是PTCA的一种有用辅助手段,可延长充盈时间,并可能使PTCA能够安全地应用于有显著心肌缺血风险或左心室储备有限的患者,目前认为这些患者进行该手术风险太大。

相似文献

1
Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.经导管输注20%氧合全氟三丙胺乳剂预防经皮腔内冠状动脉成形术期间的局部缺血。
Circulation. 1986 Sep;74(3):555-62. doi: 10.1161/01.cir.74.3.555.
2
Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol DA 20%.通过经导管向冠状动脉远端灌注20%含氧全氟三丙胺乳剂,在经皮腔内冠状动脉成形术期间保存左心室射血分数。
Am Heart J. 1988 Jun;115(6):1156-64. doi: 10.1016/0002-8703(88)90002-6.
3
Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol.使用含氧全氟三丙胺在经皮腔内冠状动脉成形术期间减少心肌缺血
Am J Cardiol. 1990 Aug 1;66(3):279-84. doi: 10.1016/0002-9149(90)90836-p.
4
Does intracoronary infusion of Fluosol-DA 20% prevent left ventricular diastolic dysfunction during coronary balloon angioplasty?冠状动脉内输注20%全氟萘烷能否预防冠状动脉球囊血管成形术期间的左心室舒张功能障碍?
J Am Coll Cardiol. 1990 Oct;16(4):959-66. doi: 10.1016/s0735-1097(10)80349-3.
5
Protection against ischemia during prolonged balloon inflation by distal coronary perfusion with use of an autoperfusion catheter or Fluosol.
J Am Coll Cardiol. 1992 Nov 15;20(6):1378-84. doi: 10.1016/0735-1097(92)90251-h.
6
Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions.冠状动脉内输注动脉血或20%氟碳化合物对短暂冠状动脉闭塞期间局部心肌代谢和功能的影响。
Circulation. 1987 Feb;75(2):473-81. doi: 10.1161/01.cir.75.2.473.
7
Metabolic and functional effects of perfluorocarbon distal perfusion during coronary angioplasty.冠状动脉血管成形术期间全氟化碳远端灌注的代谢和功能影响。
Am J Cardiol. 1990 Apr 15;65(15):986-90. doi: 10.1016/0002-9149(90)91001-m.
8
Dissociation of ST segment elevation and regional wall motion with open-artery, intracoronary Fluosol.ST段抬高与区域壁运动分离伴开放动脉、冠状动脉内氟碳化合物。
Am Heart J. 1989 Oct;118(4):679-85. doi: 10.1016/0002-8703(89)90579-6.
9
Distal coronary artery perfusion during percutaneous transluminal coronary angioplasty.经皮腔内冠状动脉成形术期间的冠状动脉远端灌注。
Am Heart J. 1985 Oct;110(4):720-6. doi: 10.1016/0002-8703(85)90448-x.
10
Perfluorochemical perfusion during coronary angioplasty in unstable and high-risk patients.不稳定型和高危患者冠状动脉血管成形术期间的全氟化合物灌注
Circulation. 1990 Mar;81(3 Suppl):IV27-34.

引用本文的文献

1
Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.血液代用品:从非载液到携氧和载气液体的演变。
ASAIO J. 2013 Jul-Aug;59(4):337-54. doi: 10.1097/MAT.0b013e318291fbaa.
2
Use of an oxygen-carrying blood substitute to improve intravascular optical coherence tomography imaging.使用携氧血液替代品改善血管内光学相干断层扫描成像。
J Biomed Opt. 2009 May-Jun;14(3):034028. doi: 10.1117/1.3153895.
3
[Artificial oxygen carriers as an alternative to red blood cell transfusion].[人工氧载体作为红细胞输血的替代物]
Anaesthesist. 2005 Aug;54(8):741-54. doi: 10.1007/s00101-005-0893-3.
4
Myocardial protection during coronary angioplasty.冠状动脉血管成形术期间的心肌保护
Tex Heart Inst J. 1992;19(4):305; author reply 305-6.
5
Myocardial protection during coronary angioplasty.冠状动脉血管成形术期间的心肌保护
Tex Heart Inst J. 1992;19(2):112-22.
6
HbXL99 alpha: a hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute.
Proc Natl Acad Sci U S A. 1987 Oct;84(20):7280-4. doi: 10.1073/pnas.84.20.7280.
7
Phagocytic activation of human neutrophils by the detergent component of fluosol.氟碳化合物的去污剂成分对人中性粒细胞的吞噬激活作用。
Am J Pathol. 1992 May;140(5):1081-7.